An opportunity to invest in Broski, one of the fastest growing Whisky brands of 2004, to support its continued expansion.

Castlemere (DK) Limited is a fast-growing Private Residential Real Estate Developer already responsible for several successful projects.

It creates aspirational and affordable modular penthouse living environments for the private residential market across London and the Southeast.

Its Current project is Vision House in Wimbledon, SW London, a collection of 1,2 and 3 bed residences.

Click here to find out more and how to invest. 

Interested in investing in the media sector?  This is the latest investment opportiunity from KickStart Capital.

Check out the latest investment opportunity from KickStart Capital to invest in fast growing healthcare brand Maxwellia.

For more information click on this link HERE

The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

For more information click this link HERE: 

The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

Opportunity to invest in fast growing whisky brand Broski - an HMRC Approved Investment with projected 382% profit.

Investment opportunity in Castlemere Developments latest project.

Addlington-West Legal (part of Addlington-West Group Limited is raising funds to expand, offering between 20% - 25% fixed returns 18 months with 100% capital protection.

Pioneering semiconductor company, Nanusens, is set to revolutionise next generation mobile phones with more sensors to make them smarter plus new antenna tuner technology to handle more data.

4% fixed annual return (paid monthly) - UK Property Investment - Proven track record.

Find out more about how to invest here.

Ingenion Medical has been awarded a CE Mark for cymactive™ 2.0R, its novel indwelling catheter designed to mimic natural urination, a key milestone for the business. With the CE Mark, Ingenion can start European-wide sales and marketing of the company’s innovative first catheter, indicated for men experiencing chronic, non-neurogenic urinary retention.

Ingenion is seeking to raise up to £3 million this year to support commercialisation of its 1st medical device to treat chronic, non-neurogenic retention, as well as the further development of its device to treat chronic female incontinence & retention.

To date, Ingenion has raised over £4.8 million in equity from High Net Worth Investors and family offices in the UK, the USA and other countries. In addition, Ingenion has been awarded four grants, including its latest grant announced on 10 April 2024.

To find out more about this exciting company and how you can invest go to our Funding Pages website to see the full investment ad.

Read the full press release here https://ingenionmedical.co.uk/ingenion-medical-announces-ce-mark-for-cymactive/